| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |